{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:40:25Z","timestamp":1785559225402,"version":"3.56.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ejca.2017.10.031","type":"journal-article","created":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T21:00:43Z","timestamp":1512507643000},"page":"100-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Improved stratification of pT1 melanoma according to the 8th American Joint Committee on Cancer staging edition criteria: A Dutch population-based study"],"prefix":"10.1016","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0034-3575","authenticated-orcid":false,"given":"D.","family":"Verver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.J.","family":"Louwman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Koljenovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Verhoef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.J.","family":"Gr\u00fcnhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.C.J.","family":"van Akkooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2017.10.031_bib1","series-title":"Netherlands comprehensive cancer registration (IKNL)","year":"2016"},{"key":"10.1016\/j.ejca.2017.10.031_bib2","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1365-2133.2012.11125.x","article-title":"Melanoma incidence and mortality in Europe: new estimates, persistent disparities","volume":"167","author":"Forsea","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2017.10.031_bib3","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/jdv.12236","article-title":"Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015","volume":"28","author":"Arnold","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2017.10.031_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ijc.11360","article-title":"Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia","volume":"107","author":"de Vries","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2017.10.031_bib5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/bmj.38516.649537.E0","article-title":"Skin biopsy rates and incidence of melanoma: population based ecological study","volume":"331","author":"Welch","year":"2005","journal-title":"Bmj"},{"key":"10.1016\/j.ejca.2017.10.031_bib6","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2016.10.018","article-title":"Mortality burden and prognosis of thin melanomas overall and by subcategory of thickness, SEER registry data, 1992-2013","volume":"76","author":"Landow","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2017.10.031_bib7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2147\/CLEP.S99021","article-title":"Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature","volume":"8","author":"Svedman","year":"2016","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.ejca.2017.10.031_bib8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/CMR.0000000000000312","article-title":"Incidence trends and clinical-pathological characteristics of invasive cutaneous melanoma from 1980 to 2010 in the Canton of Zurich, Switzerland","volume":"27","author":"Minini","year":"2017","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ejca.2017.10.031_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv294","article-title":"Melanoma thickness, and survival trends in the United States, 1989 to 2009","volume":"108","author":"Shaikh","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2017.10.031_bib10","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/jid.2014.452","article-title":"More people die from thin melanomas (1 mm) than from thick melanomas (>4 mm) in Queensland, Australia","volume":"135","author":"Whiteman","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2017.10.031_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejca.2015.11.026","article-title":"The burden of malignant melanoma\u2013lessons to be learned from Austria","volume":"56","author":"Monshi","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2017.10.031_bib12","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"issue":"Suppl 5","key":"10.1016\/j.ejca.2017.10.031_bib13","doi-asserted-by":"crossref","first-page":"v126","DOI":"10.1093\/annonc\/mdv297","article-title":"Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Dummer","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2017.10.031_bib14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejca.2016.05.005","article-title":"Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - update 2016","volume":"63","author":"Garbe","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2017.10.031_bib15","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1200\/JCO.2011.40.3519","article-title":"Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline","volume":"30","author":"Wong","year":"2012","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2017.10.031_bib16","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3322\/caac.21409","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejca.2017.10.031_bib17","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1200\/JCO.2013.50.1114","article-title":"Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma","volume":"31","author":"Han","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2017.10.031_bib18","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa060992","article-title":"Sentinel-node biopsy or nodal observation in melanoma","volume":"355","author":"Morton","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2017.10.031_bib19","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1245\/s10434-012-2469-1","article-title":"Sentinel node biopsy is indicated for thin melanomas >\/=0.76 mm","volume":"19","author":"Han","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2017.10.031_bib20","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1200\/JCO.2013.54.2340","article-title":"Prediction of survival in patients with thin melanoma: results from a multi-institution study","volume":"32","author":"Maurichi","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2017.10.031_bib21","series-title":"Dutch working group on melanoma","year":"2012"},{"key":"10.1016\/j.ejca.2017.10.031_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"key":"10.1016\/j.ejca.2017.10.031_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/sim.1597","article-title":"Regression models for relative survival","volume":"23","author":"Dickman","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.ejca.2017.10.031_bib24","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/annonc\/mdr128","article-title":"Trends of cutaneous melanoma in The Netherlands: increasing incidence rates among all Breslow thickness categories and rising mortality rates since 1989","volume":"23","author":"Hollestein","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2017.10.031_bib25","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1016\/j.ejca.2015.09.008","article-title":"Increasing time trends of thin melanomas in The Netherlands: what are the explanations of recent accelerations?","volume":"51","author":"van der Leest","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2017.10.031_bib26","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/01.DSS.0000452619.94264.ff","article-title":"Mitotic rate for thin melanomas: should a single mitotic figure warrant a sentinel lymph node biopsy?","volume":"40","author":"Kirkland","year":"2014","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ejca.2017.10.031_bib27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jaad.2015.09.014","article-title":"A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas","volume":"74","author":"Wat","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2017.10.031_bib28","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/ijc.30607","article-title":"Implementation of the 7th edition AJCC staging system: effects on staging and survival for pT1 melanoma. A Dutch population based study","volume":"140","author":"Oude Ophuis","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2017.10.031_bib29","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.suronc.2017.08.006","article-title":"Practice variation in Sentinel Lymph Node Biopsy for melanoma patients in different geographical regions in The Netherlands","volume":"26","author":"Verstijnen","year":"2017","journal-title":"Surg Oncol"},{"key":"10.1016\/j.ejca.2017.10.031_bib30","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1245\/s10434-014-3764-9","article-title":"Factors influencing the use of sentinel lymph node biopsy in The Netherlands","volume":"21","author":"Huismans","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2017.10.031_bib31","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1245\/ASO.2006.04.023","article-title":"The prognostic importance of sentinel lymph node biopsy in thin melanoma","volume":"13","author":"Ranieri","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2017.10.031_bib32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1684\/ejd.2010.0837","article-title":"Sentinel lymph node biopsy in patients with thin melanoma: occurrence of nodal metastases and its prognostic value","volume":"20","author":"Vermeeren","year":"2010","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.ejca.2017.10.031_bib33","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/SLA.0b013e3182306c72","article-title":"Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma","volume":"255","author":"Murali","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2017.10.031_bib34","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1001\/jamadermatol.2017.2497","article-title":"Association between patient age and lymph node positivity in thin melanoma","volume":"153","author":"Sinnamon","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2017.10.031_bib35","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1245\/s10434-013-3092-5","article-title":"Reproducibility of AJCC staging parameters in primary cutaneous melanoma: an analysis of 4,924 cases","volume":"20","author":"Niebling","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2017.10.031_bib36","first-page":"910","article-title":"Mitotic rate in primary melanoma: interobserver and intraobserver reliability, analyzed using H&E sections and immunohistochemistry","volume":"14","author":"Garbe","year":"2016","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.ejca.2017.10.031_bib37","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/bjd.12898","article-title":"Impact of mitotic activity on the pathological substaging of pT1 cutaneous melanoma","volume":"170","author":"de Waal","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2017.10.031_bib38","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/bjd.12095","article-title":"Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark's level of invasion: results of a population-based study from the Swedish Melanoma Register","volume":"168","author":"Lyth","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2017.10.031_bib39","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejca.2016.11.021","article-title":"Dutch Melanoma Treatment Registry: quality assurance in the care of patients with metastatic melanoma in The Netherlands","volume":"72","author":"Jochems","year":"2017","journal-title":"Eur J Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804917313710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804917313710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T20:56:01Z","timestamp":1603486561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804917313710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":39,"alternative-id":["S0959804917313710"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2017.10.031","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved stratification of pT1 melanoma according to the 8th American Joint Committee on Cancer staging edition criteria: A Dutch population-based study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2017.10.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}